Suppr超能文献

免疫抑制药物 LF15-0195 还通过改变足细胞细胞骨架分布来作用于肾小球病变。

The Immunosuppressive Drug LF15-0195 Acts Also on Glomerular Lesions, by a Change in Cytoskeleton Distribution in Podocyte.

机构信息

Center for Research in Transplantation and Translational Immunology, UMR 1064, ITUN, CHU Nantes, Nantes Université, INSERM, Nantes, France.

Regenerative Medicine and Skeleton, RMeS, UMR 1229, Oniris, Nantes Université, INSERM, Nantes, France.

出版信息

Am J Nephrol. 2024;55(5):583-596. doi: 10.1159/000539965. Epub 2024 Jul 29.

Abstract

INTRODUCTION

Buffalo/Mna rats spontaneously develop nephrotic syndrome (NS) which recurs after renal transplantation. The immunosuppressive drug LF15-0195 can promote regression of the initial and post-transplantation nephropathy via induction of regulatory T cells. We investigate if this drug has an additional effect on the expression and localization of podocyte specific proteins.

METHODS

Buffalo/Mna kidney samples were collected before and after the occurrence of proteinuria, and after the remission of proteinuria induced by LF15-0195 treatment and compared by quantitative RT-PCR, Western blot, electron, and confocal microscopy to kidney samples of age-matched healthy rats. Cytoskeleton changes were assessed in culture by stress fibers induction by TNFα.

RESULTS

We observed, by electron microscopy, a restoration of foot process architecture in the LF15-0195-treated Buff/Mna kidneys, consistent with proteinuria remission. Nephrin, podocin, CD2AP, and α-actinin-4 mRNA levels remained low during the active disease in the Buff/Mna, in comparison with healthy rats which increase, while podocalyxin and synaptopodin transcripts were elevated before the occurrence of the disease but did not differ from healthy animals after. No difference in the mRNA and protein expression between the untreated and the LF15-0195-treated proteinuric Buff/Mna were seen for these 6 proteins. No changes were observed by confocal microscopy in the protein distribution at a cellular level, but a more homogenous distribution similar to healthy rats, was observed within the glomeruli of LF15-0195-treated rats. In addition, LF15-0195 could partially restore actin cytoskeleton of endothelial cells in TNFα-induced-cell stress experiment.

CONCLUSION

The effect of LF15-0195 treatment appears to be mediated by 2 mechanisms: an immunomodulatory effect via regulatory T cells induction, described in our previous work and which can act on immune cell involved in the disease pathogenesis, and an effect on the restoration of podocyte cytoskeleton, independent of expression levels of the proteins involved in the slit diaphragm and podocyte function, showed in this article.

摘要

简介

布法罗/曼纳大鼠自发形成肾病综合征(NS),肾移植后会复发。免疫抑制剂 LF15-0195 可通过诱导调节性 T 细胞促进初始和移植后肾病的消退。我们研究了该药物是否对足细胞特异性蛋白的表达和定位有额外的影响。

方法

在蛋白尿发生前、发生后以及 LF15-0195 治疗诱导蛋白尿缓解后,收集布法罗/曼纳大鼠的肾脏样本,并通过定量 RT-PCR、Western blot、电子显微镜和共聚焦显微镜与年龄匹配的健康大鼠的肾脏样本进行比较。通过 TNFα诱导的应激纤维评估细胞骨架在培养中的变化。

结果

电镜观察到 LF15-0195 治疗的布法罗/曼纳肾脏足突结构得到恢复,与蛋白尿缓解一致。与健康大鼠相比,在布法罗/曼纳活跃期,足细胞蛋白 Nephrin、podocin、CD2AP 和 α-actinin-4 的 mRNA 水平较低,而 podocalyxin 和 synaptopodin 的转录物在疾病发生前升高,但疾病发生后与健康动物无差异。未经处理和 LF15-0195 治疗的蛋白尿布法罗/曼纳大鼠之间,这些 6 种蛋白的 mRNA 和蛋白表达无差异。在细胞水平上,共聚焦显微镜观察到蛋白分布没有变化,但 LF15-0195 治疗的大鼠肾小球内观察到更均匀的分布,类似于健康大鼠。此外,LF15-0195 可部分恢复 TNFα诱导的细胞应激实验中内皮细胞的肌动蛋白细胞骨架。

结论

LF15-0195 治疗的效果似乎通过 2 种机制介导:我们之前的工作描述了通过诱导调节性 T 细胞的免疫调节作用,这可能作用于参与疾病发病机制的免疫细胞,以及本文中显示的对足细胞细胞骨架的恢复作用,独立于参与裂孔隔膜和足细胞功能的蛋白的表达水平。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验